ACVRL1 and neoplasm: The combined dysregulation of VEGF/VEGFR, BMP9/ALK1 and Dll4/Notch signaling pathways can lead to a more profound effects on tumor angiogenesis delaying the development of acquired resistance to VEGFR TKI in RCC.